Altrova Health FY26 nine-month net loss widens to C$2.35 million; revenue more than doubled to C$112,000

• Altrova Health posted nine-month revenue of CAD 112,000, more than doubled from CAD 15,551 a year earlier.
• Net loss widened to CAD 2.35 million from CAD 1.1 million in the prior-year period.
• Gross margin fell 6.6 percentage points to 55.8%, while gross profit rose to CAD 62,488.
• Loss expansion was driven by a CAD 330,640 non-cash license write-off, plus higher non-cash share-based compensation.
• Management highlighted first meaningful product revenue, ongoing NIRLAB device sales, cross-border uplisting, and lower discretionary costs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Altrova Health Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608311837NEWSFILECNPR____20260831_312309_1) on August 31, 2026, and is solely responsible for the information contained therein.